18 results
Venous Thromboembolism Treatment Algorithm
Branch points: 
Active bleeding?  Active malignancy? Provoked?

- Dr. Joseph Shatzel
@Clotmaster

#Management #VTE #DVT
Venous Thromboembolism ... Treatment Algorithm ... @Clotmaster #Management ... #VTE #DVT #Algorithm ... #Treatment #Hematology
Treatment Algorithm for First Time DVT
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke, MD.

#DVT
Treatment Algorithm ... #DVT #Treatment ... #Algorithm #management ... #hematology #VTE ... #thrombosis #venous
IDSA Recommended therapy for patients with Lyme disease.

#Management #InfectiousDiseases #Antibiotics #LymeDisease #Treatment #Regimens #Duration #IDSA
IDSA Recommended ... #Management #InfectiousDiseases ... #LymeDisease #Treatment ... #Regimens #Duration ... #IDSA
Treatment Algorithm for First Time Pulmonary Embolism
 • Provoked
 • Unprovoked
 • Active Malignancy

By Carlin Rooke,
Treatment Algorithm ... Pulmonary #Embolism #Treatment ... #Algorithm #management ... #hematology #VTE ... #thrombosis #venous
Candidemia Workup and Management - IDSA Guidelines
1) Antibiotics
 • Empiric: Echinocandins (e.g. micafungin) for most patients
Candidemia Workup and Management ... - IDSA Guidelines ... Susceptibilities, Negative ... due to central venous ... #candidiasis #treatment
Bacteremia Quick Reference - Treatment Duration

Gram Negative Bacteremia:
 • Avoid: Aminoglycosides and tigecycline
 • Catheters should
Quick Reference - Treatment ... Duration Gram ... #Bacteremia #Treatment ... #Management #Duration ... #infectiousdiseases
2019 EULAR recommendations for thrombosis in (Antiphospholipid Syndrome) APS
Venous Thrombosis - Arterial Thrombosis
INR Target
Duration
Recurrence

Dr. Laurent ARNAUD
Syndrome) APS Venous ... Thrombosis INR Target Duration ... Syndrome #APS #management ... EULAR2019 #guidelines #rheumatology ... #hematology #treatment
Algorithm for treatment of a Central Line Associated Bloodstream Infection (CLABSI)

#CLABSI #Algorithm #CentralLine #Infection #Management #InfectiousDiseases
Algorithm for treatment ... CLABSI) #CLABSI #Algorithm ... CentralLine #Infection #Management ... #InfectiousDiseases ... #Treatment #Duration
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary
 • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
Diagnosis and Management ... evocative of SLE versus ... pANCA anti-MPO - Negative ... life-threatening • Treatment ... #Summary #rheumatology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... for the treatment ... mass index; VTE = venous ... Anticoagulation #Management ... #Hematology #Oncology